Asthma inhaler recall: GlaxcoSmithKline pulls nearly 600,000 devices from shelves Business News

Looking for:

ventolin 

Click here

The recall only affects the U.S. market and does not extend to patients. The defect does not pose an immediate danger to patients, though it could cause the inhaler to deliver a lower dose of the medicine than specified on the package. Users are asked to return any inhalers they have already purchased. The FDA says a level II recall means use of the device "may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." Drugmaker GSK recalling nearly 600,000 asthma inhalers in U.S. In April 2017, GlaxoSmithKline announced they were recalling almost 600,000 Ventolin HFA inhalers because a propellant leakage in the inhalers had caused them to emit a lower dosage of the medication albuterol.

On 21 February 2018, the company announced a separate recall of certain lots of the Ventolin Accuhaler in the U.K. Once again, the cause was a manufacturing problem which led to "a small number of units not delivering the full number of doses," according to the U.K. Prices displayed on Our Platform are outside of Our control and may vary at any time. We provide no warranty regarding the accuracy, availability, or applicability of any of the pricing data or other information on Our Platform. The pricing estimates given are based on the most recent information available and may have changed when the prescription is filled at the pharmacy.

This isn't the first time Glaxo has had to recall Ventolin inhalers. In December 2015, the company voluntarily recalled around 129,000 Ventolin HFA inhalers because of insufficient propellant to deliver the 200 doses. The voluntary recall affects three batches of Ventolin HFA 200D inhalers manufactured at a GlaxoSmithKline plant in North Carolina, according to a U.S. The company started pulling the prescription-only product from hospitals, pharmacies and wholesalers March 22. British pharmaceutical company GlaxoSmithKline is recalling more than a half a million asthma inhalers due to a defect.

GlaxoSmithKline is voluntarily recalling Ventolin HFA Inhalation Aerosol 90 mcg per actuation, 200 Metered inhalations. A check of the web sites of the Food and Drug Administration and GlaxoSmithKline showed there was no new Ventolin inhaler recall in February 2018. When you block a person, they can no longer invite you to a private message or post to your profile wall. Replies and comments they make will be collapsed/hidden by default.

But, as recent setbacks have shown, researchers and drugmakers still face major challenges. The the asthma medication contained in Ventolin — albuterol, also known as salbutamol — is listed as one of the World Health Organization's essential medicines for both children and adults. GlaxoSmithKline initiated a voluntary recall of the product on April 4, according toAsthma and Allergy Foundation of America’s website. The Ventolin HFA inhaler, first approved by FDA in 2001, is for use in patients age 4 years or older to treat or prevent bronchospasm in those with reversible obstructive airway disease and to prevent exercise-induced bronchospasm. The defect does not pose a danger to patients, so they are not being asked to return inhalers they have already purchased. The U.S. Food and Drug Administration has approved the voluntary “Level 2” recall, which only affects products in the United States, GSK spokesman Juan Carlos Molina said.

The recall involves three lots of the Ventolin HFA 200D inhalers manufactured at GSK’s plant in Zebulon, North Carolina. Reutersreports GSK has issued a voluntary Level II recall of Ventolin inhalers from U.S. hospitals, pharmacies, retailers and wholesalers. More than 593,000 inhalers may have a defect that causes them to administer fewer doses of medicine than indicated, according to the company. After an elevated number of complaints, drugmaker GSK Plc announced on Tuesday that it is voluntarily recalling nearly 600,000 Ventolin asthma inhalers from hospitals, pharmacies, wholesalers and retailers in the United States. British drugmaker GlaxoSmithKline is voluntarily recalling three lots of its 200-dose Ventolin inhalers from hospitals, pharmacies and wholesalers. Albuterol sulfate is a life-saving medication that reduces the tightening of airway muscles and the inflammation of the airway lining.

However, a severe attack requires immediate use of albuterol and medical attention. If untreated, the attack will worsen until unconsciousness and eventually death occur. Being without a properly working albuterol inhaler in your or your child’s time of need can be incredibly traumatic and life-threatening. Three lots of Ventolin HFA 200D inhalers have been voluntarily recalled due to a potential issue with the delivery system.